Cost-Effectiveness Analysis of Therapies for Chronic Kidney Disease Patients on Dialysis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2012-11

AUTHORS

Daniel T. Grima, Lisa M. Bernard, Elizabeth S. Dunn, Philip A. McFarlane, David C. Mendelssohn

ABSTRACT

In many jurisdictions, cost-effectiveness analysis (CEA) plays an important role in determining drug coverage and reimbursement and, therefore, has the potential to impact patient access. Health economic guidelines recommend the inclusion of future costs related to the intervention of interest within CEAs but provide little guidance regarding the definition of 'related'. In the case of CEAs of therapies that extend the lives of patients with chronic kidney disease (CKD) on dialysis but do not impact the need for or the intensity of dialysis, the determination of the relatedness of future dialysis costs to the therapy of interest is particularly ambiguous. The uncertainty as to whether dialysis costs are related or unrelated in these circumstances has led to inconsistencies in the conduct of CEAs for such products, with dialysis costs included in some analyses while excluded in others. Due to the magnitude of the cost of dialysis, whether or not dialysis costs are included in CEAs of such therapies has substantial implications for the results of such analyses, often meaning the difference between a therapy being deemed cost effective (in instances where dialysis costs are excluded) or not cost effective (in instances where dialysis costs are included). This paper explores the issues and implications surrounding the inclusion of dialysis costs in CEAs of therapies that extend the lives of dialysis patients but do not impact the need for dialysis. Relevant case studies clearly demonstrate that, regardless of the clinical benefits of a life-extending intervention for dialysis patients, and due to the high cost of dialysis, the inclusion of dialysis costs in the analysis essentially eliminates the possibility of obtaining a favourable cost-effectiveness ratio. This raises the significant risk that dialysis patients may be denied access to interventions that are cost effective in other populations due solely to the high background cost of dialysis itself. Finally, the paper presents a case for excluding dialysis costs in CEAs of therapies that extend the lives of patients receiving dialysis but do not impact the need for dialysis. The argument is founded on the following: (i) health economic guidelines imply that dialysis costs are unrelated to such therapies and therefore should not be included in CEAs of such therapies; (ii) the high cost and cost-effectiveness ratio associated with dialysis place an unreasonable and insurmountable barrier to demonstrating the cost effectiveness of such therapies, particularly since the decision to fund dialysis has already been made; and (iii) current clinical and reimbursement practices include the use of such therapies for patients with CKD receiving dialysis. We conclude that the exclusion of dialysis costs in such cases is methodologically correct given current health economic guidelines and is consistent with current practices regarding the treatment of dialysis patients. More... »

PAGES

981-989

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/11599390-000000000-00000

DOI

http://dx.doi.org/10.2165/11599390-000000000-00000

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1024392794

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22946789


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cost-Benefit Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Guidelines as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Services Accessibility", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insurance Coverage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reimbursement Mechanisms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Renal Dialysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Renal Insufficiency, Chronic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Cornerstone Research Group, 204-3228 South Service Road, ON L7N 3H8, Burlington, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grima", 
        "givenName": "Daniel T.", 
        "id": "sg:person.0712642556.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712642556.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Cornerstone Research Group, 204-3228 South Service Road, ON L7N 3H8, Burlington, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bernard", 
        "givenName": "Lisa M.", 
        "id": "sg:person.01321515016.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321515016.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sanofi (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417555.7", 
          "name": [
            "Genzyme Corporation, Boston, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dunn", 
        "givenName": "Elizabeth S.", 
        "id": "sg:person.01170665704.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170665704.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Michael's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415502.7", 
          "name": [
            "St. Michael\u2019s Hospital, Toronto, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McFarlane", 
        "givenName": "Philip A.", 
        "id": "sg:person.01007621250.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007621250.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Humber River Regional Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413632.1", 
          "name": [
            "Humber River Regional Hospital, Toronto, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mendelssohn", 
        "givenName": "David C.", 
        "id": "sg:person.0737235611.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737235611.70"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1053/j.ajkd.2010.07.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001339309"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jhealeco.2007.09.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007333643"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.ajkd.2008.06.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008418601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0272989x0002000310", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009330846"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0272989x0002000310", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009330846"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1258/000456306775141623", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009680232"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1258/000456306775141623", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009680232"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0167-6296(96)00506-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010631761"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.323.7324.1300", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012703093"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/030079908x260853", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021689059"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ndt/gfm367", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023447345"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hec.1065", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026936724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hec.1065", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026936724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.329.7459.224", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028231127"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0167-6296(96)00507-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033257642"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.ajkd.2007.05.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036417054"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1258/135581907779497567", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038468378"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1258/135581907779497567", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038468378"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hec.864", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042609173"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hec.1279", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042715723"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1524-4733.2008.00401.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044678320"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hec.850", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046637228"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ndt/17.12.2196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048088068"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.39434.500185.25", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049177028"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hec.1066", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050826171"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hec.1066", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050826171"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmsb032612", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053365050"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3310/hta11180", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071138969"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-11", 
    "datePublishedReg": "2012-11-01", 
    "description": "In many jurisdictions, cost-effectiveness analysis (CEA) plays an important role in determining drug coverage and reimbursement and, therefore, has the potential to impact patient access. Health economic guidelines recommend the inclusion of future costs related to the intervention of interest within CEAs but provide little guidance regarding the definition of 'related'. In the case of CEAs of therapies that extend the lives of patients with chronic kidney disease (CKD) on dialysis but do not impact the need for or the intensity of dialysis, the determination of the relatedness of future dialysis costs to the therapy of interest is particularly ambiguous. The uncertainty as to whether dialysis costs are related or unrelated in these circumstances has led to inconsistencies in the conduct of CEAs for such products, with dialysis costs included in some analyses while excluded in others. Due to the magnitude of the cost of dialysis, whether or not dialysis costs are included in CEAs of such therapies has substantial implications for the results of such analyses, often meaning the difference between a therapy being deemed cost effective (in instances where dialysis costs are excluded) or not cost effective (in instances where dialysis costs are included). This paper explores the issues and implications surrounding the inclusion of dialysis costs in CEAs of therapies that extend the lives of dialysis patients but do not impact the need for dialysis. Relevant case studies clearly demonstrate that, regardless of the clinical benefits of a life-extending intervention for dialysis patients, and due to the high cost of dialysis, the inclusion of dialysis costs in the analysis essentially eliminates the possibility of obtaining a favourable cost-effectiveness ratio. This raises the significant risk that dialysis patients may be denied access to interventions that are cost effective in other populations due solely to the high background cost of dialysis itself. Finally, the paper presents a case for excluding dialysis costs in CEAs of therapies that extend the lives of patients receiving dialysis but do not impact the need for dialysis. The argument is founded on the following: (i) health economic guidelines imply that dialysis costs are unrelated to such therapies and therefore should not be included in CEAs of such therapies; (ii) the high cost and cost-effectiveness ratio associated with dialysis place an unreasonable and insurmountable barrier to demonstrating the cost effectiveness of such therapies, particularly since the decision to fund dialysis has already been made; and (iii) current clinical and reimbursement practices include the use of such therapies for patients with CKD receiving dialysis. We conclude that the exclusion of dialysis costs in such cases is methodologically correct given current health economic guidelines and is consistent with current practices regarding the treatment of dialysis patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.2165/11599390-000000000-00000", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1102812", 
        "issn": [
          "1170-7690", 
          "1179-2027"
        ], 
        "name": "PharmacoEconomics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "30"
      }
    ], 
    "name": "Cost-Effectiveness Analysis of Therapies for Chronic Kidney Disease Patients on Dialysis", 
    "pagination": "981-989", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "7435a24de60a0656d4fa0f3aa796f0113abd5e94ac5d318db8b690ecd7667024"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22946789"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9212404"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/11599390-000000000-00000"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1024392794"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/11599390-000000000-00000", 
      "https://app.dimensions.ai/details/publication/pub.1024392794"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T13:14", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8659_00000505.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.2165%2F11599390-000000000-00000"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/11599390-000000000-00000'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/11599390-000000000-00000'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/11599390-000000000-00000'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/11599390-000000000-00000'


 

This table displays all metadata directly associated to this object as RDF triples.

208 TRIPLES      21 PREDICATES      60 URIs      29 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/11599390-000000000-00000 schema:about N17d782adc6d04a03b03e794e1b90bebf
2 N2be8cb5827c14cedacec33613b7c353f
3 N9fbdcbd9a3c94f789448d56cc23b3ff4
4 Na267448b23d74471b0e79222b4ea17e9
5 Nae5b8a11291a4e6ba676683a17501ce1
6 Nb4dce1b8cc1e4f2db742e13c0d9c236c
7 Nce98ae3aa9b44d80ac54c29c3e157110
8 Nee4954a747d14f798a946d1926600ed4
9 anzsrc-for:11
10 anzsrc-for:1103
11 schema:author Nc6ae49732c7d40e8957424f6921447e4
12 schema:citation https://doi.org/10.1002/hec.1065
13 https://doi.org/10.1002/hec.1066
14 https://doi.org/10.1002/hec.1279
15 https://doi.org/10.1002/hec.850
16 https://doi.org/10.1002/hec.864
17 https://doi.org/10.1016/j.jhealeco.2007.09.011
18 https://doi.org/10.1016/s0167-6296(96)00506-1
19 https://doi.org/10.1016/s0167-6296(96)00507-3
20 https://doi.org/10.1053/j.ajkd.2007.05.019
21 https://doi.org/10.1053/j.ajkd.2008.06.015
22 https://doi.org/10.1053/j.ajkd.2010.07.015
23 https://doi.org/10.1056/nejmsb032612
24 https://doi.org/10.1093/ndt/17.12.2196
25 https://doi.org/10.1093/ndt/gfm367
26 https://doi.org/10.1111/j.1524-4733.2008.00401.x
27 https://doi.org/10.1136/bmj.323.7324.1300
28 https://doi.org/10.1136/bmj.329.7459.224
29 https://doi.org/10.1136/bmj.39434.500185.25
30 https://doi.org/10.1177/0272989x0002000310
31 https://doi.org/10.1185/030079908x260853
32 https://doi.org/10.1258/000456306775141623
33 https://doi.org/10.1258/135581907779497567
34 https://doi.org/10.3310/hta11180
35 schema:datePublished 2012-11
36 schema:datePublishedReg 2012-11-01
37 schema:description In many jurisdictions, cost-effectiveness analysis (CEA) plays an important role in determining drug coverage and reimbursement and, therefore, has the potential to impact patient access. Health economic guidelines recommend the inclusion of future costs related to the intervention of interest within CEAs but provide little guidance regarding the definition of 'related'. In the case of CEAs of therapies that extend the lives of patients with chronic kidney disease (CKD) on dialysis but do not impact the need for or the intensity of dialysis, the determination of the relatedness of future dialysis costs to the therapy of interest is particularly ambiguous. The uncertainty as to whether dialysis costs are related or unrelated in these circumstances has led to inconsistencies in the conduct of CEAs for such products, with dialysis costs included in some analyses while excluded in others. Due to the magnitude of the cost of dialysis, whether or not dialysis costs are included in CEAs of such therapies has substantial implications for the results of such analyses, often meaning the difference between a therapy being deemed cost effective (in instances where dialysis costs are excluded) or not cost effective (in instances where dialysis costs are included). This paper explores the issues and implications surrounding the inclusion of dialysis costs in CEAs of therapies that extend the lives of dialysis patients but do not impact the need for dialysis. Relevant case studies clearly demonstrate that, regardless of the clinical benefits of a life-extending intervention for dialysis patients, and due to the high cost of dialysis, the inclusion of dialysis costs in the analysis essentially eliminates the possibility of obtaining a favourable cost-effectiveness ratio. This raises the significant risk that dialysis patients may be denied access to interventions that are cost effective in other populations due solely to the high background cost of dialysis itself. Finally, the paper presents a case for excluding dialysis costs in CEAs of therapies that extend the lives of patients receiving dialysis but do not impact the need for dialysis. The argument is founded on the following: (i) health economic guidelines imply that dialysis costs are unrelated to such therapies and therefore should not be included in CEAs of such therapies; (ii) the high cost and cost-effectiveness ratio associated with dialysis place an unreasonable and insurmountable barrier to demonstrating the cost effectiveness of such therapies, particularly since the decision to fund dialysis has already been made; and (iii) current clinical and reimbursement practices include the use of such therapies for patients with CKD receiving dialysis. We conclude that the exclusion of dialysis costs in such cases is methodologically correct given current health economic guidelines and is consistent with current practices regarding the treatment of dialysis patients.
38 schema:genre research_article
39 schema:inLanguage en
40 schema:isAccessibleForFree false
41 schema:isPartOf N8aa8e94b37b44a448ec0d48d9240d2cd
42 Ne7f71a936e0b413589218f22a8ecc1d3
43 sg:journal.1102812
44 schema:name Cost-Effectiveness Analysis of Therapies for Chronic Kidney Disease Patients on Dialysis
45 schema:pagination 981-989
46 schema:productId N30e6c49649a548c4bdd98a050377f3bb
47 N58bcb6bd9ca5485bacb942a8e00029fc
48 Na78316c1ef2942f6a2728a287ed98f1c
49 Naa6ce2932174425da9860d6b22236964
50 Nb4eb6629381647c3bed0f680f4406c38
51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024392794
52 https://doi.org/10.2165/11599390-000000000-00000
53 schema:sdDatePublished 2019-04-10T13:14
54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
55 schema:sdPublisher N215b0a3d77e04397a56e75763f5cc14c
56 schema:url http://link.springer.com/10.2165%2F11599390-000000000-00000
57 sgo:license sg:explorer/license/
58 sgo:sdDataset articles
59 rdf:type schema:ScholarlyArticle
60 N011cd9d1418940e5a6ec1e5957a6b9c8 schema:name Cornerstone Research Group, 204-3228 South Service Road, ON L7N 3H8, Burlington, Ontario, Canada
61 rdf:type schema:Organization
62 N14ab6fd6f4af4420893e91fce189233d rdf:first sg:person.01170665704.06
63 rdf:rest N672ca60b231f4561abfdd5722e5e8256
64 N17d782adc6d04a03b03e794e1b90bebf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Reimbursement Mechanisms
66 rdf:type schema:DefinedTerm
67 N215b0a3d77e04397a56e75763f5cc14c schema:name Springer Nature - SN SciGraph project
68 rdf:type schema:Organization
69 N2be8cb5827c14cedacec33613b7c353f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Health Services Accessibility
71 rdf:type schema:DefinedTerm
72 N30e6c49649a548c4bdd98a050377f3bb schema:name pubmed_id
73 schema:value 22946789
74 rdf:type schema:PropertyValue
75 N39f4a012636c4e158e0b5294f7e2c4c5 rdf:first sg:person.0737235611.70
76 rdf:rest rdf:nil
77 N58bcb6bd9ca5485bacb942a8e00029fc schema:name doi
78 schema:value 10.2165/11599390-000000000-00000
79 rdf:type schema:PropertyValue
80 N672ca60b231f4561abfdd5722e5e8256 rdf:first sg:person.01007621250.78
81 rdf:rest N39f4a012636c4e158e0b5294f7e2c4c5
82 N8aa8e94b37b44a448ec0d48d9240d2cd schema:issueNumber 11
83 rdf:type schema:PublicationIssue
84 N8feef2d4f9904c218afb762cc92b4cbd schema:name Cornerstone Research Group, 204-3228 South Service Road, ON L7N 3H8, Burlington, Ontario, Canada
85 rdf:type schema:Organization
86 N99786a5a16804054bd981c42e70d6b7a rdf:first sg:person.01321515016.76
87 rdf:rest N14ab6fd6f4af4420893e91fce189233d
88 N9fbdcbd9a3c94f789448d56cc23b3ff4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Cost-Benefit Analysis
90 rdf:type schema:DefinedTerm
91 Na267448b23d74471b0e79222b4ea17e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Insurance Coverage
93 rdf:type schema:DefinedTerm
94 Na78316c1ef2942f6a2728a287ed98f1c schema:name readcube_id
95 schema:value 7435a24de60a0656d4fa0f3aa796f0113abd5e94ac5d318db8b690ecd7667024
96 rdf:type schema:PropertyValue
97 Naa6ce2932174425da9860d6b22236964 schema:name dimensions_id
98 schema:value pub.1024392794
99 rdf:type schema:PropertyValue
100 Nae5b8a11291a4e6ba676683a17501ce1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Humans
102 rdf:type schema:DefinedTerm
103 Nb4dce1b8cc1e4f2db742e13c0d9c236c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Renal Insufficiency, Chronic
105 rdf:type schema:DefinedTerm
106 Nb4eb6629381647c3bed0f680f4406c38 schema:name nlm_unique_id
107 schema:value 9212404
108 rdf:type schema:PropertyValue
109 Nc6ae49732c7d40e8957424f6921447e4 rdf:first sg:person.0712642556.16
110 rdf:rest N99786a5a16804054bd981c42e70d6b7a
111 Nce98ae3aa9b44d80ac54c29c3e157110 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Guidelines as Topic
113 rdf:type schema:DefinedTerm
114 Ne7f71a936e0b413589218f22a8ecc1d3 schema:volumeNumber 30
115 rdf:type schema:PublicationVolume
116 Nee4954a747d14f798a946d1926600ed4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Renal Dialysis
118 rdf:type schema:DefinedTerm
119 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
120 schema:name Medical and Health Sciences
121 rdf:type schema:DefinedTerm
122 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
123 schema:name Clinical Sciences
124 rdf:type schema:DefinedTerm
125 sg:journal.1102812 schema:issn 1170-7690
126 1179-2027
127 schema:name PharmacoEconomics
128 rdf:type schema:Periodical
129 sg:person.01007621250.78 schema:affiliation https://www.grid.ac/institutes/grid.415502.7
130 schema:familyName McFarlane
131 schema:givenName Philip A.
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007621250.78
133 rdf:type schema:Person
134 sg:person.01170665704.06 schema:affiliation https://www.grid.ac/institutes/grid.417555.7
135 schema:familyName Dunn
136 schema:givenName Elizabeth S.
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170665704.06
138 rdf:type schema:Person
139 sg:person.01321515016.76 schema:affiliation N8feef2d4f9904c218afb762cc92b4cbd
140 schema:familyName Bernard
141 schema:givenName Lisa M.
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321515016.76
143 rdf:type schema:Person
144 sg:person.0712642556.16 schema:affiliation N011cd9d1418940e5a6ec1e5957a6b9c8
145 schema:familyName Grima
146 schema:givenName Daniel T.
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712642556.16
148 rdf:type schema:Person
149 sg:person.0737235611.70 schema:affiliation https://www.grid.ac/institutes/grid.413632.1
150 schema:familyName Mendelssohn
151 schema:givenName David C.
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737235611.70
153 rdf:type schema:Person
154 https://doi.org/10.1002/hec.1065 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026936724
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1002/hec.1066 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050826171
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1002/hec.1279 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042715723
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1002/hec.850 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046637228
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1002/hec.864 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042609173
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1016/j.jhealeco.2007.09.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007333643
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1016/s0167-6296(96)00506-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010631761
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/s0167-6296(96)00507-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033257642
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1053/j.ajkd.2007.05.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036417054
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1053/j.ajkd.2008.06.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008418601
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1053/j.ajkd.2010.07.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001339309
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1056/nejmsb032612 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053365050
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1093/ndt/17.12.2196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048088068
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1093/ndt/gfm367 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023447345
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1111/j.1524-4733.2008.00401.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1044678320
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1136/bmj.323.7324.1300 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012703093
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1136/bmj.329.7459.224 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028231127
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1136/bmj.39434.500185.25 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049177028
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1177/0272989x0002000310 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009330846
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1185/030079908x260853 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021689059
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1258/000456306775141623 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009680232
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1258/135581907779497567 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038468378
197 rdf:type schema:CreativeWork
198 https://doi.org/10.3310/hta11180 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071138969
199 rdf:type schema:CreativeWork
200 https://www.grid.ac/institutes/grid.413632.1 schema:alternateName Humber River Regional Hospital
201 schema:name Humber River Regional Hospital, Toronto, Ontario, Canada
202 rdf:type schema:Organization
203 https://www.grid.ac/institutes/grid.415502.7 schema:alternateName St. Michael's Hospital
204 schema:name St. Michael’s Hospital, Toronto, Ontario, Canada
205 rdf:type schema:Organization
206 https://www.grid.ac/institutes/grid.417555.7 schema:alternateName Sanofi (United States)
207 schema:name Genzyme Corporation, Boston, Massachusetts, USA
208 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...